Abstract
The focus of this conference report is to present and highlight some selected topics and emerging trends from this excellent annual conference hosted by Select Biosciences Ltd. at the Wyndham Palm Springs. This conference attracted a worldwide audience of more than 100 delegates representing a number of different areas – basic researchers involved with stem cells, representatives from pharmaceutical, biotechnology and vendor companies, a diverse array of industry participants from the cord blood banking industry as well as stem-cell clinics from around the world. The scope of industry coverage presented at this conference included stem cells in regenerative medicine, pluripotency/induced pluripotent stem cells/epigenetics and biobanking. These categories represented the major themes into which the bulk of the presentations at this conference were organized. By far, the major thrust of this conference was on the application of stem cells for regenerative medicine – in this regard it is important to note that mesenchymal stem cells are the most promising types of adult stem cells for regenerative medicine and cellular therapy. Many presentations at this conference were focused around mesenchymal stem cells for cellular therapy in a number of different disease areas.
Financial & competing interests disclosure
The author works with System Biosciences LLC (SBI, LLC), which produces reagents and tools for stem-cell research. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.